BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

785 related articles for article (PubMed ID: 15288991)

  • 1. Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.
    Chan WM; Lam DS; Lai TY; Liu DT; Li KK; Yao Y; Wong TH
    Ophthalmology; 2004 Aug; 111(8):1576-84. PubMed ID: 15288991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-year outcomes of photodynamic therapy in age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients.
    Gomi F; Ohji M; Sayanagi K; Sawa M; Sakaguchi H; Oshima Y; Ikuno Y; Tano Y
    Ophthalmology; 2008 Jan; 115(1):141-6. PubMed ID: 17582498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularization: one-year results from a prospective case series.
    Chan WM; Lam DS; Wong TH; Lai TY; Kwok AK; Tam BS; Li KK
    Ophthalmology; 2003 Dec; 110(12):2395-402. PubMed ID: 14644724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extensive submacular haemorrhage in polypoidal choroidal vasculopathy managed by sequential gas displacement and photodynamic therapy: a pilot study of one-year follow up.
    Chan WM; Liu DT; Lai TY; Li H; Tong JP; Lam DS
    Clin Exp Ophthalmol; 2005 Dec; 33(6):611-8. PubMed ID: 16402954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization.
    Eandi CM; Ober MD; Freund KB; Slakter JS; Yannuzzi LA
    Retina; 2007 Sep; 27(7):825-31. PubMed ID: 17891004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photodynamic therapy with verteporfin for symptomatic circumscribed choroidal hemangioma: five-year outcomes.
    Blasi MA; Tiberti AC; Scupola A; Balestrazzi A; Colangelo E; Valente P; Balestrazzi E
    Ophthalmology; 2010 Aug; 117(8):1630-7. PubMed ID: 20417564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.
    Yamashita A; Shiraga F; Shiragami C; Ono A; Tenkumo K
    Am J Ophthalmol; 2010 Mar; 149(3):465-71.e1. PubMed ID: 20042180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.
    Verteporfin In Photodynamic Therapy Study Group
    Am J Ophthalmol; 2001 May; 131(5):541-60. PubMed ID: 11336929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy with verteporfin in polypoidal choroidal vasculopathy: results after 3 years of follow-up.
    Leal S; Silva R; Figueira J; Cachulo ML; Pires I; de Abreu JR; Cunha-Vaz JG
    Retina; 2010 Sep; 30(8):1197-205. PubMed ID: 20827139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial.
    Chan WM; Lai TY; Lai RY; Liu DT; Lam DS
    Ophthalmology; 2008 Oct; 115(10):1756-65. PubMed ID: 18538401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study.
    Schmidt-Erfurth U; Miller JW; Sickenberg M; Laqua H; Barbazetto I; Gragoudas ES; Zografos L; Piguet B; Pournaras CJ; Donati G; Lane AM; Birngruber R; van den Berg H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
    Arch Ophthalmol; 1999 Sep; 117(9):1177-87. PubMed ID: 10496389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin.
    Silva RM; Figueira J; Cachulo ML; Duarte L; Faria de Abreu JR; Cunha-Vaz JG
    Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):973-9. PubMed ID: 15864616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-year results of reduced-fluence photodynamic therapy for polypoidal choroidal vasculopathy.
    Yamashita A; Shiraga F; Shiragami C; Shirakata Y; Fujiwara A
    Am J Ophthalmol; 2013 Jan; 155(1):96-102.e1. PubMed ID: 22995028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy.
    Kang HM; Kim YM; Koh HJ
    Am J Ophthalmol; 2013 Mar; 155(3):438-447.e1. PubMed ID: 23218705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, outcomes, and risk factors for hemorrhagic complications in eyes with polypoidal choroidal vasculopathy following photodynamic therapy in Indian subjects.
    Rishi P; Rishi E; Sharma M; Maitray A; Bhende M; Gopal L; Sharma T; Ratra D; Sen P; Bhende P; Rao C; Susvar P
    Indian J Ophthalmol; 2017 Aug; 65(8):712-718. PubMed ID: 28820157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin.
    Chan WM; Lam DS; Lai TY; Yuen KS; Liu DT; Chan CK; Chen WQ
    Am J Ophthalmol; 2003 Nov; 136(5):836-45. PubMed ID: 14597034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy.
    Koh A; Lee WK; Chen LJ; Chen SJ; Hashad Y; Kim H; Lai TY; Pilz S; Ruamviboonsuk P; Tokaji E; Weisberger A; Lim TH
    Retina; 2012 Sep; 32(8):1453-64. PubMed ID: 22426346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy with verteporfin for polypoidal choroidal vasculopathy of the macula.
    Lee SC; Seong YS; Kim SS; Koh HJ; Kwon OW
    Ophthalmologica; 2004; 218(3):193-201. PubMed ID: 15103216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photodynamic therapy combined with ranibizumab for polypoidal choroidal vasculopathy: results of a 1-year preliminary study.
    Ruamviboonsuk P; Tadarati M; Vanichvaranont S; Hanutsaha P; Pokawattana N
    Br J Ophthalmol; 2010 Aug; 94(8):1045-51. PubMed ID: 20530656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.